These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23703924)

  • 1. Next generation therapeutics for Alzheimer's disease.
    Bredesen DE; John V
    EMBO Mol Med; 2013 Jun; 5(6):795-8. PubMed ID: 23703924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.
    Koffie RM; Hashimoto T; Tai HC; Kay KR; Serrano-Pozo A; Joyner D; Hou S; Kopeikina KJ; Frosch MP; Lee VM; Holtzman DM; Hyman BT; Spires-Jones TL
    Brain; 2012 Jul; 135(Pt 7):2155-68. PubMed ID: 22637583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
    Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
    Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: The forgetting gene.
    Spinney L
    Nature; 2014 Jun; 510(7503):26-8. PubMed ID: 24899289
    [No Abstract]   [Full Text] [Related]  

  • 6. What's next for Alzheimer treatment?: while Aβ isn't out of the picture yet, several other therapeutic routes are being explored.
    Schwartz A
    Ann Neurol; 2013 Apr; 73(4):A7-9. PubMed ID: 24643982
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular cholesterol homeostasis and Alzheimer's disease.
    Chang TY; Yamauchi Y; Hasan MT; Chang C
    J Lipid Res; 2017 Dec; 58(12):2239-2254. PubMed ID: 28298292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer disease: Alzheimer dementia with sparse amyloid-AD mimic or variant?
    Serrano-Pozo A; Hyman BT
    Nat Rev Neurol; 2015 Dec; 11(12):674-5. PubMed ID: 26553593
    [No Abstract]   [Full Text] [Related]  

  • 10. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
    Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO
    Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer's disease in an induced neuron.
    Kim H; Yoo J; Shin J; Chang Y; Jung J; Jo DG; Kim J; Jang W; Lengner CJ; Kim BS; Kim J
    Brain; 2017 Aug; 140(8):2193-2209. PubMed ID: 28899010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Conflicting Neuropathological Findings in Patients Clinically Diagnosed as Having Alzheimer Dementia.
    Salloway S; Sperling R
    JAMA Neurol; 2015 Oct; 72(10):1106-8. PubMed ID: 26302229
    [No Abstract]   [Full Text] [Related]  

  • 14. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
    Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.
    Habib A; Sawmiller D; Tan J
    J Neurosci Res; 2017 Apr; 95(4):973-991. PubMed ID: 27531392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.
    Oliver DMA; Reddy PH
    J Alzheimers Dis; 2019; 72(s1):S95-S116. PubMed ID: 30932888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice.
    Chan ES; Chen C; Cole GM; Wong BS
    Sci Rep; 2015 Sep; 5():13842. PubMed ID: 26346625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.
    Landel V; Millet P; Baranger K; Loriod B; Féron F
    Mol Neurodegener; 2016 Mar; 11():22. PubMed ID: 26932723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.